A long-term study of the hematological and metabolic effects of a low-dose monophasic oral contraceptive containing gestodene

References

• Inman W. H. W., Vessey M.P. Investigations of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women ofchildbearingage. Br. Med. J. 1968; 2: 193–9
   PubMed Web of Science ®Google Scholar
• Mann J.I., Inman W. H. W. Oral contraceptives and death from myocardial infarction. Br. Med J. 1975; 2: 245–8
   PubMed Web of Science ®Google Scholar
• Fotherby K. Oral contraceptives, lipids and cardiovascular disease. Contraception 1985; 31: 367–94
   PubMed Web of Science ®Google Scholar
• Gaspard U.J. Metabolic effects of oral contraceptives. Am. J. Obstet. Gynecol. 1987; 157: 1029–41
   PubMed Web of Science ®Google Scholar
• Stadel B.V. Oral contraceptives and cardiovascular disease (two parts). N. Engl. J. Med. 1981; 305: 612–18, 672–7
   PubMed Web of Science ®Google Scholar
• Stampfer M.J., Willet W.C., Colditz G.A., Speizer F.E., Hennekens C.H. A prospective study of past use of oral contraceptive agents and risk of cardiovascular disease. N. Engl. J. Med. 1988; 319: 1313–17
   PubMed Web of Science ®Google Scholar
• Tikkanen M.J., Nikkila E.A. Oral contraceptives and lipoprotein metabolism. J. Reprod. Med. 1986; 31: 898–906
   PubMed Web of Science ®Google Scholar
• Kay C.R. Progestogens and arterial disease. Evidence from the Royal College of General Practitioners' study. Am. J. Obstet. Gynecol. 1982; 142: 762–5
   PubMed Web of Science ®Google Scholar
• Bottiger L.E., Westerholm B. Oral contraceptives and thromboembolic disease. Acta Med. Scand. 1971; 190: 455–63
   PubMedGoogle Scholar
• Inman W. H. W., Vessey M.P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br. Med. J. 1970; 2: 203–9
   PubMed Web of Science ®Google Scholar
• Sartwell P.E., Masi A.T., Arthes F.G., Greene G.R., Smith H.E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am. J. Epidemiol. 1969; 90: 365–80
   PubMed Web of Science ®Google Scholar
• Mann J.I., Vessey M.P., Thorogood M., Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br. Med. J. 1975; 2: 241–7
   PubMed Web of Science ®Google Scholar
• Bergquist A., Bergquist D., Hedner U. Oral contraception and venous thromboembolism. Br. J. Obstet. Gynaecol. 1982; 89: 381–6
   PubMedGoogle Scholar
• Irey N.S., Manion W.C., Taylor H.B. Vascular lesions in women taking oral contraceptives. Arch. Pathol. 1970; 89: 1–8
   PubMedGoogle Scholar
• Radford D., Oliver M.F. Oral contraceptives and myocardial infarction. Br. Med. J. 1973; 2: 428–30
   PubMedGoogle Scholar
• Ramcharan S., Pellegrin F.A., Ray R.M., Hsu J.P. The Walnut Creek Contraceptive Drug Study. A prospective study of the side-effects of oral contraceptives. J. Reprod. Med. 1980; 25(Suppl.)346–72
   Google Scholar
• Notelovitz M. Oral contraception and coagulation. Clin. Obstet. Gynecol. 1985; 28: 73–83
   PubMed Web of Science ®Google Scholar
• Spellacy W.N. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Am. J. Obstet. Gynecol. 1982; 42: 732–4
   Google Scholar
• Bagdade J.D., Subbaiah P.V., Hintz R.L., Wilson D.L. The measurement of arterial smooth muscle cell mitogens in the blood of oral contraceptive users. Arteriosclerosis 1985; 56: 149–55
   Google Scholar
• Deslypere J.P., Thiery M., Vermeulen A. Effect of long-term hormonal contraception on plasma lipids. Contraception 1985; 31: 633–42
   PubMed Web of Science ®Google Scholar
• Burkman R.T. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy. Fertil. Steril. 1988; 49(Suppl. 1)39–50
   Google Scholar
• Guaschino S., Solerte S.B., Spinillo A., Fioravanti M., Ferrari E. Metabolic, hemostatic and hemorheological parameters in normal cycle and in triphasic oral contraceptive long-term users. Gynecol. Endocrinol. 1988; 2(Suppl. 2)176a
   Google Scholar
• Solerte S.B., Fioravanti M., Spinillo A., Ferrari E., Guaschino S. Influence of triphasic oral contraceptives on blood rheology and haemostatic and metabolic patterns in young women. Results of a three-year study. J. Reprod. Med. 1992; 37: 725–32
   PubMed Web of Science ®Google Scholar
• Sabra A., Bonnar J. Haemostatic system changes induced by 50 μg and 30 μg estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel. J. Reprod. Med. 1983; 28: 85–91
   PubMed Web of Science ®Google Scholar
• Bonnar J., Daly L., Carroll E. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol. Int. J. Fertil 1987; 32(Suppl.)21–8
   PubMedGoogle Scholar
• Spona J., Huber J. Pharmacological and endocrine profiles of gestodene. Int. J. Fertil. 1987; 32(Suppl.)6–14
   PubMedGoogle Scholar
• Wells R.E., Denton R., Merrill E.W. Measurement of viscosity of biologic fluids by cone plate viscometer. J. Lab. Clin. Med. 1961; 57: 646–56
   PubMed Web of Science ®Google Scholar
• Reid H.L., Barnes A.J., Lock P.I., Dormandy J.A., Dormandy T.L. A simple method for measuring erythrocyte deformability. J. Clin. Pathol. 1976; 29: 855–8
   PubMed Web of Science ®Google Scholar
• Laurell C. Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Analyt. Biochem. 1966; 15: 42–52
   Web of Science ®Google Scholar
• Soloni F.G., Sardina L.C. Colorimetric micro determination of free fatty acids. Clin. Chem. 1973; 19: 419–26
   PubMed Web of Science ®Google Scholar
• Solerte S.B., Fioravanti M., Ferrari E. Plasma fibronectin as an indicator of microvascular damage in diabetic patients. Rapid and sensitive evaluation by a radial immunodiffusion technique. Ric. Clin. Lab. 1987; 17: 251–8
   PubMedGoogle Scholar
• Noble R.P., Hatch F.F., Mazzimas J.A., Lindgren F.T., Jensen L.C., Adamson G.L. Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultra centrifugation. Lipids 1968; 4: 55–61
   Web of Science ®Google Scholar
• Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 1973; 19: 476–82
   PubMed Web of Science ®Google Scholar
• Allein C.C., Poon L.S., Chan G. S. G., Richmond W., Fu P.L. Enzymatic detemination of total serum cholesterol. Clin. Chem. 1974; 20: 470–5
   PubMedGoogle Scholar
• Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low-density cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499–506
   PubMed Web of Science ®Google Scholar
• Warnick G.R., Albers J.J. Comprehensive evaluation of the heparin manganese precipitation procedure for the estimation of high density lipoprotein cholesterol. J. Lipid Res. 1978; 19: 65–72
   PubMed Web of Science ®Google Scholar
• Meade T.W. Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am. J. Obstet. Gynecol. 1988; 158: 1646–52
   PubMed Web of Science ®Google Scholar
• Sondheimer S. Metabolic effects of the birth control pill. Clin. Obstet. Gynecol. 1981; 24: 927–41
   PubMedGoogle Scholar
• Woods J.W. Oral contraceptives and hypertension. Hypertension 1988; 11(Suppl. II)11–15
   Google Scholar
• Dormandy J.A. Haemorrheological aspects of thrombosis. Br. J. Haematol. 1980; 45: 519–22
   PubMed Web of Science ®Google Scholar
• Lowe G. D. O., Forbes C D. Blood rheology and thrombosis. Clin. Haematol. 1981; 10: 343–67
   PubMedGoogle Scholar
• Solerte S.B., Adamo S., Bagliani F., Spinillo A., Guaschino S., Ferrari E. Haemorheological changes in healthy women throughout the menstrual cycle. (Abstr.). Clin. Haemorrheol. 1985; 5: 746a
   Google Scholar
• Solerte S.B., Fioravanti M., Spinillo A., Ferrari E., Guaschino S. Association between hormonal and haemorrheological changes during the menstrual cycle in healthy women. Br. J. Obstet. Gynaecol. 1988; 95: 1305–8
   PubMedGoogle Scholar
• Solerte S.B., Fioravanti M., Spinillo A., Guaschino S., Ferrari E. Influence des hormones sexuelles sur lˆhemorheologie et les pro-teines plasmatiques au cours du cycle menstruel. Rev. Fr. Gynecol. Obstet. 1991; 86(Suppl. 2)139–42
   PubMedGoogle Scholar
• Solerte S.B., Fioravanti M., Spinillo A., Iasci A., Ferrari E., Guaschino S. Effects of serum androgens on blood rheology, plasma fibronectin and acute-phase protein pattern during normal menstrual cycle. It. J. Gynaecol. Obstet. 1991; 2: 54–9
   Google Scholar
• Buchan P.C., MacDonald M.N. Altered haemorrheology in oral contraceptive users. Br. Med. J. 1980; 1: 978–9
   Google Scholar
• Lowe G. D. O., Drummond M.M., Forbes C.D., Barbenel J.C. Increased blood viscosity in young women using oral contraceptives. Am. J. Obstet. Gynecol. 1980; 137: 840–2
   PubMed Web of Science ®Google Scholar
• Poller L., Thompson J.M., Thomas W. Oestrogen/progestogen oral contraception and blood clotting: a long-term follow-up. Br. Med. J. 1971; 1: 648–50
   Google Scholar
• Solerte S.B., Piovella F., Viola C., Carnevale Schianca G.P., Gamba G., Fioravanti M., Ferrari E. Plasma fibronectin, Von Wille-brand factor antigen, and blood rheology. Association with diabetic microvascular disease. Acta Diabet. Lat. 1985; 22: 239–46
   PubMedGoogle Scholar